Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

582
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
582
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

688
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
688
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

1.1K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Unraveling the anti-inflammatory mechanism of <i>Dolichos lablab</i> flower extract: synergistic action of bioactive flavonoids <i>via</i> multi-target modulation.

Food & function·2026
Same author

In Situ Translation of Terminal Glycans into Covalent Readouts in Complex Biological Systems.

Analytical chemistry·2026
Same author

Case Report: First occurrence of smoldering multiple myeloma in activated phosphoinositide 3-Kinase δ syndrome.

Frontiers in oncology·2026
Same author

Effect of Pore Structure Parameters on Thermal Insulation Performance of Porous Ceramics Fabricated by Material Jetting.

Materials (Basel, Switzerland)·2026
Same author

Research Progress on Preparation Technology, Structure Optimization and Properties of 3D-Printed Porous Ceramics.

Materials (Basel, Switzerland)·2026
Same author

Infrared radiation-assisted drying stabilizes rice flavor by modulating volatile composition and lipid metabolism.

Food chemistry·2026
Same journal

A Muscle-Mimetic Core-Sheath Composite Yarn Scaffold for In-Body Tissue Induction and Regeneration of Small-Diameter Vascular Grafts.

Advanced healthcare materials·2026
Same journal

Gardiquimod Nanoemulsion Targets Cutaneous Leishmaniasis Lesions Reducing Systemic Toxicity and Parasite Burden.

Advanced healthcare materials·2026
Same journal

Therapeutic Extracellular Vesicles from Synovial Fibroblast-Primed MSCs for Osteoarthritis Treatment.

Advanced healthcare materials·2026
Same journal

Natural Polysaccharide-Mediated Nano-Delivery Systems for Osteoporosis Therapy From a Gut-Bone Axis Regulatory Perspective.

Advanced healthcare materials·2026
Same journal

A Corrigendum on "Selenium-Albumin Nanoaccelerator Hydrogel Promotes Wound Healing by Antibacterial, Anti-Inflammatory and Antioxidant along with Inhibits Scar Formation via Down-regulating CD36".

Advanced healthcare materials·2026
Same journal

High-Throughput Digital Decoding of Vascular Heterogeneity in Patient-Specific Tumor Microenvironments.

Advanced healthcare materials·2026
查看所有相关文章

相关实验视频

Updated: Mar 11, 2026

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
06:53

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells

Published on: June 2, 2022

3.9K

合成抗体模拟剂与ROS-Gated糖释放用于向性结肠炎治疗.

Yan Zhang1, Song Li2, Qiang Li1

  • 1State Key Laboratory of Analytical Chemistry For Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China.

Advanced healthcare materials
|March 10, 2026
PubMed
概括
此摘要是机器生成的。

研究人员开发了用于炎症性肠病 (IBD) 的新型ROS激活纳米药物. 这些智能聚合物向炎症组织,改善愈合并重新平衡肠道微生物群.

关键词:
IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD在ROS-响应释放的释放中.有分子印记的聚合物.粘液屏障是一种粘液屏障.有针对性的糖输送.

更多相关视频

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

2.1K
Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

7.4K

相关实验视频

Last Updated: Mar 11, 2026

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
06:53

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells

Published on: June 2, 2022

3.9K
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

2.1K
Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

7.4K

科学领域:

  • 生物材料科学 生物材料科学
  • 纳米医学是一种纳米医学.
  • 胃肠病学 胃肠病学

背景情况:

  • 常规针对性治疗炎症性肠病 (IBD) 面临的挑战是由于不稳定的生物识别元素.
  • 分子印记聚合物 (MIP) 提供了强大的合成替代品,但遭受非特异性结合,限制其有效性.
  • 现有的疗法缺乏精确的控制在炎症环境中的目标参与.

研究的目的:

  • 为IBD治疗设计反应性氧物种 (ROS) 激活的治疗执行器.
  • 开发一个系统,克服静态MIP的局限性,通过实现受控的,特定地点的准.
  • 创建智能纳米药物,以增强粘膜愈合和IBD中的微生物组调节.

主要方法:

  • 通过ROS可切割的链接器将曼诺斯与转移林印制的MIP结合起来,以创建响应式执行器.
  • 使用曼诺作为治疗剂和固体屏蔽,以防止运输过程中发生非特异性结合.
  • 研究ROS触发的激活在炎症部位的高亲和性表皮向和屏障形成.

主要成果:

  • 开发的MIP显示了双重功能:非特异性结合的固体阻断和ROS激活的向.
  • 在小鼠结肠炎模型中,纳米药物实现了显著的粘膜愈合和炎症缓解.
  • 观察到微生物群的再平衡,其疗效与剂量为27.2 mg/kg/d的免费曼诺斯相当.

结论:

  • 这项研究提出了一种可通用的策略,用于开发针对性药物输送的对疾病有反应的纳米药物.
  • 由ROS激活的MIP提供了一个有前途的平台来治疗IBD,通过实现精确的识别和局部治疗作用.
  • 这种方法为智能纳米药物铺平了道路,适应复杂的生理环境,以改善治疗结果.